Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients

Neurology

Volumn 69, Issue 10, 2007, Pages 953-958

  Blanc, F ^a,c   Jaulhac, B ^a,c   Fleury, M ^a   De Seze, J ^a,c   De Martino, S J ^a,c   Remy, V ^a   Blaison, G ^b   Hansmann, Y ^a,c   Christmann, D ^a,c   Tranchant, C ^a,c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Pasteur Hospital   (France)

^c GEBLY (Study Group for Lyme Borreliosis)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MENINGITIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEROLOGY; SYMPTOMATOLOGY;

ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; HUMANS; LYME NEUROBORRELIOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 34548432547     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000269672.17807.e0     Document Type: Article

References (25)

1. Pachner AR. Borrelia burgdorferi in the nervous system: the new "great imitator." Ann NY Acad Sci 1988;539:56-64.
2. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998;245:262-272.
3. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990: a prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. 1992;Brain 115 (pt 2):399-423.
4. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis: peripheral nervous system manifestations. Brain 1990;113 (pt 4):1207-1221.
5. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991;41:1571-1582.
6. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-1444.
7. Stanek G, O'Connell S, Cimmino M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996;108:741-747.
8. Wilske B, Schierz G, Preac-Mursic V, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986;153:304-314.
9. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. Morb Mortal Wkly Rep 1997;46:1-55.
10. Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 1985;21:819-825.
11. Hansen K, Cruz M, Link H. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1990;161:1194-1202.
12. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161:1203-1209.
13. Picha D, Moravcova L, Zdarsky E, Benes J. Clinical comparison of immunoblot and antibody index for detection of intrathecal synthesis of specific antibodies in Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 2000;19:805-806.
14. Tumani H, Nolker G, Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 1995;45:1663-1670.
15. Hauser U, Krahl H, Peters H, Fingerle V, Wilske B. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1998;36:427-436.
16. Robertson J, Guy E, Andrews N, et al. A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol 2000;38:2097-2102.
17. Kaiser R, Lucking CH. Intrathecal synthesis of specific antibodies in neuroborreliosis: comparison of different ELISA techniques and calculation methods. J Neurol Sci 1993;118:64-72.
18. Clavelou P, Vernay D, Cuoq N, et al. Les atteintes démyé linisantes au cours des neuropathies borréliennes. Rev Neurol (Paris) 1993;149:320-325.
19. Halperin JJ, Kaplan GP, Brazinsky S, et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 1990;47:586-594.
20. Li L, Narayan K, Pak E, Pachner AR. Intrathecal antibody production in a mouse model of Lyme neuroborreliosis. J Neuroimmunol 2006;173:56-68.
21. Kruger H, Reuss K, Pulz M, et al. Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol 1989;236:322-328.
22. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996;46:619-627.
23. Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol 1991;48:1125-1129.
24. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry 1994;151:1571-1583.
25. Zhioua E, Rodhain F, Binet P, Perez-Eid C. Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Eur J Epidemiol 1997;13:959-962.